Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Companies
Recent news which mentions Companies
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
30
31
Next >
Qatari royal reportedly invested $50 million in pro-Trump news channel Newsmax
March 27, 2024
Tags
US Top News and Analysis
World Politics
US: News
From
CNBC.com News
Moderna moves three vaccines into final stage trials as it works to rebound from Covid slump
March 27, 2024
Tags
Biotech and Pharmaceuticals
Science
Business News
From
CNBC.com News
FDA approves Merck's drug for rare, deadly lung condition
March 26, 2024
Tags
Science
Biotech and Pharmaceuticals
Breaking news
From
CNBC.com News
Moderna says new Covid vaccine showed stronger immune response than current shot in study
March 26, 2024
Tags
Pharmaceuticals
Companies
Health & Science
From
CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
March 26, 2024
Tags
Biotech and Pharmaceuticals
Science
Viking Therapeutics Inc
From
CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
March 24, 2024
Tags
Health care industry
Business News
Novo Nordisk A/S
From
CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
March 23, 2024
Tags
Business
Pharmaceuticals
Health & Science
From
CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
March 21, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Social issues
From
CNBC.com News
Dubai's Parkin surges 30% on trading debut in UAE's first IPO of the year
March 21, 2024
Tickers
IPO
IPOS
Tags
Economy
Breaking News: Markets
Emerging markets
From
CNBC.com News
Saudi Arabia's massive wealth fund is in talks to acquire national airline Saudia: Report
March 18, 2024
Tags
Transportation
Travel
Tourism
From
CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
March 16, 2024
Tags
Biotechnology
Eli Lilly and Co
US: News
From
CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
March 14, 2024
Tags
Madrigal Pharmaceuticals Inc
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
March 13, 2024
Tags
Companies
Pharmaceuticals
Health & Science
From
CNBC.com News
Airbnb bans use of all indoor security cameras to 'prioritize the privacy' of guests
March 12, 2024
Tags
Europe News
Airbnb Inc
US: News
From
CNBC.com News
Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
March 10, 2024
Tags
Pfizer Inc
Business News
Health care industry
From
CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
March 08, 2024
Tags
Business News
Health care industry
Business
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Eisai Co Ltd
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Cigna launches effort to cap employer insurance plan spending on weight loss drugs
March 07, 2024
Tags
Business
Companies
Pharmaceuticals
From
CNBC.com News
Biden says Medicare should negotiate prices for at least 50 drugs each year, up from a target of 20
March 06, 2024
Tags
Companies
Pharmaceuticals
Health & Science
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024
Tags
Novo Nordisk A/S
Science
Biotech and Pharmaceuticals
From
CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
March 03, 2024
Tags
Business News
Health care industry
Breaking news
From
CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
March 01, 2024
Tags
Pharmaceuticals
Companies
Health & Science
From
CNBC.com News
CVS and Walgreens to start selling abortion pill mifepristone this month
March 01, 2024
Tags
Business
CVS Health Corp
Pharmaceuticals
From
CNBC.com News
British telco giant BT expects to launch 5G standalone — or 'true' 5G — later this year
March 01, 2024
Tags
Breaking News: Markets
Media
Breaking News: Technology
From
CNBC.com News
Here's what tech giants are betting on next — from robot dogs to smartphones you can wear on your wrist
February 29, 2024
Tags
Autos
Lenovo Group Ltd
Electric vehicles
From
CNBC.com News
Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
February 29, 2024
Tags
US: News
Moderna Inc
Biotechnology
From
CNBC.com News
Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs
February 28, 2024
Tags
Earnings
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Viking Therapeutics stock jumps 80% after positive weight loss drug trial results
February 27, 2024
Tags
Biotech and Pharmaceuticals
Viking Therapeutics Inc
Pfizer Inc
From
CNBC.com News
Bank CEO shrugs off U.S. war on 'woke' capital, says ESG investing is good for business
February 27, 2024
Tickers
CEO
CEOS
Tags
CEOs
Business News
CEO
From
CNBC.com News
EToro wants to bring its trading app to Apple Vision Pro and Meta Quest headsets
February 27, 2024
Tags
Internet
Technology: Trends
Companies
From
CNBC.com News
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
30
31
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.